Tivozanib + Gemcitabine in Metastatic RCC

Clinical trial NCT01834183 · WITHDRAWN

Trial details

NCT number: NCT01834183
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2013-06-01
Primary completion: 2013-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.